US challenges ‘bogus’ patents on Ozempic, other drugs to spur competition 0 01.05.2024 03:10 Las Vegas Review-Journal Federal regulators are challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
